Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Amneal Reports Third Quarter 2024 Financial Results
06:00am, Friday, 08'th Nov 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Reports Third Quarter 2024 Financial Results.
Amneal (AMRX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Wednesday, 06'th Nov 2024
Evaluate the expected performance of Amneal (AMRX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility
08:05am, Tuesday, 05'th Nov 2024
Invest in stocks of AMRX, CRON, CSV, BFST and APH to tap their high-efficiency levels.
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline
11:06am, Friday, 01'st Nov 2024
Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Find Great Cheap Stocks Under $10 to Buy in October
04:01pm, Tuesday, 15'th Oct 2024
On top of their cheap price tags, Wall Street analysts are high on all of these stocks and their improving earnings outlooks earn them strong Zacks Ranks.
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
10:40am, Monday, 14'th Oct 2024
Here is how Amneal Pharmaceuticals (AMRX) and Astrazeneca (AZN) have performed compared to their sector so far this year.
Amneal to Report Third Quarter 2024 Results on November 8, 2024
04:05pm, Tuesday, 08'th Oct 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Report Third Quarter 2024 Results on November 8, 2024.
BRIDGEWATER, N.J. & NEW YORK--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, and Metsera, Inc. (“Metsera”), a cl
Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson's Disease
08:00am, Monday, 23'rd Sep 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson's Disease.
Amneal Stock Rises 29% in a Month on Upbeat Regulatory Updates
11:57am, Tuesday, 03'rd Sep 2024
AMRX stock gains 29.3% in a month due to the FDA's approval of Parkinson's Disease drug, Crexont.
Despite Fast-paced Momentum, Amneal (AMRX) Is Still a Bargain Stock
09:50am, Wednesday, 21'st Aug 2024
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Amneal (AMRX) could be a great choice. It is one of the several stocks that passed t
5 Small Drug Stocks to Buy as Innovation Reaches Peak
09:20am, Friday, 16'th Aug 2024
Innovation is at its peak for the Zacks Medical-Drugs industry. CORT, AMRX, BVS, FHTX, and AKBA may prove to be good additions to one's portfolio.
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2024 Earnings Call Transcript
12:14pm, Friday, 09'th Aug 2024
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX ) Q2 2024 Earnings Conference Call August 9, 2024 8:30 AM ET Company Participants Tony DiMeo - Head of Investor Relations Chirag Patel - President & Co-Chief
Compared to Estimates, Amneal (AMRX) Q2 Earnings: A Look at Key Metrics
10:30am, Friday, 09'th Aug 2024
While the top- and bottom-line numbers for Amneal (AMRX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to
AMNEAL PHARMACEUTICALS, INC. (AMRX) Soars to 52-Week High, Time to Cash Out?
10:15am, Friday, 09'th Aug 2024
Amneal (AMRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
